The comeback story of belantamab mafodotin (Blenrep) hit a roadblock Thursday as the FDA's Oncologic Drugs Advisory Committee ...

Notably, Revlimid’s patent expired earlier this year, leaving a significant cash flow gap for the firm to fill. There’s no guarantee that any late-stage trials will hit the ground running.

Bristol Myers and Celgene are being sued in an antitrust suit, alleging they used fraud, sham litigation, and reverse payments to delay cheaper generics of Pomalyst.

Lenalidomide Plus Bortezomib for Relapsed and Refractory Myeloma Results of a phase 1 trial showed that combining lenalidomide and bortezomib was well tolerated, and there was promising activity ...

Taewoong Choi, MD: In the NCCN guidelines, Dara-Rd [daratumumab (Darzalex), lenalidomide (Revlimid), and dexamethasone] is one of the preferred regimens, and also now included in the recommendations ...

According to the subgroup analyses, the combination of daratumumab (Darzalex) and bortezomib (Velcade), lenalidomide (Revlimid), and dexamethasone (D-VRd) improved both responses and survival vs VRd ...

Isatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) in newly diagnosed multiple myeloma (NDMM): Outcomes in patients with 1q21+ status in the phase 3 IMROZ study.. If you have the ...

As it had done so many times in the past, Celgene tapped Revlimid to try to mitigate the damage. The day it announced the failure of the Crohn’s drug, it quietly raised the price of Revlimid by 9%.

The Price of Remission When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years.

When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered ...

Health Care Why Do Americans Pay More for Prescription Drugs? Drug companies in the U.S. face few restraints on what to charge for their products. A bipartisan bill would penalize those companies ...